Taiwan FDA registration 51c3f1dfd44a3605ada068b2b7f28fad

HemosIL Q.F.A Thrombin (Bovine)

TW: 希摩西爾纖維蛋白原試劑

Taiwan·Risk Class 2·MD·INSTRUMENTATION LABORATORY CO.·Registered Oct 09, 2018 – Oct 09, 2028Active

Registration details

Analysis ID: 51c3f1dfd44a3605ada068b2b7f28fad
License Form: Ministry of Health Medical Device Import No. 031725
Customs Code: DHA05603172507

Company information

Manufacturer: INSTRUMENTATION LABORATORY CO.
Manufacturer Country: United States
Authorized Representative: Werfen Taiwan Limited

Product details

Intended Use: This product is paired with the IL Coagulation System of the Instrument Experimental Company, which uses the Clauss method to quantify the concentration of fibrinogen in human plasma with citric acidification.
Product Type (Level 1): B Hematology and pathology devices
Product Type (Level 2): B7875 Coagulation time test
Import Information: Imported from abroad

Dates and status

Registration Date: Oct 09, 2018
Expiry Date: Oct 09, 2028

About this record

Access comprehensive regulatory information for HemosIL Q.F.A Thrombin (Bovine) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 51c3f1dfd44a3605ada068b2b7f28fad and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.